ZymoGenetics: Biology is basic

Although ZymoGenetics Inc. now has both independence and a $150 million war chest with which to bolster its discovery engine, the company will steer clear of becoming a target provider with high-throughput genomics capabilities, aiming instead to exploit its biology roots in protein therapeutics.

ZymoGenetics (Seattle, Wash.) had operated for the past

Read the full 517 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers